Penumbra(PEN.US) Officer Sells US$3.07 Million in Common Stock
$Penumbra(PEN.US)$ Officer Elsesser Adam sold 15,000 shares of common stock on Oct 21, 2024 at an average price of $204.56 for a total value of $3.07 million.Source: Announcement What is statement
Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Looking Into Penumbra's Recent Short Interest
Piper Sandler Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $225
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Penumbra (PEN)
Express News | Penumbra Inc : Piper Sandler Raises Target Price to $225 From $200
Penumbra Is Maintained at Buy by Canaccord Genuity
Penumbra Analyst Ratings
CCORF Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $235
Penumbra's Strategic Progress and Earnings Growth Justify Buy Rating With $235 Price Target
Optimistic Outlook for Penumbra Amid Recent Advancements and Market Share Gains
Penumbra Completes Enrolment for THUNDER Study to Treat Ischemic Stroke
Returns On Capital At Penumbra (NYSE:PEN) Paint A Concerning Picture
Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Nurix Therapeutics (NRIX) and Charles River Labs (CRL)
BTIG Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $234
Maintaining Hold on Penumbra Amid Balanced Growth Prospects and Market Valuation
Why Penumbra Stock Zoomed 4% Higher Today
Penumbra Is Maintained at Buy by BTIG
Penumbra Shares Are Trading Higher After the Company Announced It Completed the Enrollment in Its THUNDER Clinical Study for Patients With Acute Ischemic Stroke. Also, Truist Securities Maintained a Buy Rating on the Stock and Raised Its Price Target...
Penumbra Price Target Raised to $235.00/Share From $200.00 by Truist Securities